MARC details
000 -LEADER |
fixed length control field |
04915cam a2200541Ii 4500 |
001 - |
control field |
ocn948296971 |
003 - |
control field |
OCoLC |
005 - |
control field |
20190719103232.0 |
006 - |
fixed length control field |
m o d |
007 - |
fixed length control field |
cr cnu|||unuuu |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
160429s2016 enk ob 001 0 eng d |
040 ## - |
-- |
N$T |
-- |
eng |
-- |
rda |
-- |
pn |
-- |
N$T |
-- |
OPELS |
-- |
N$T |
-- |
YDXCP |
-- |
OCLCF |
-- |
YDX |
-- |
UPM |
-- |
U3W |
-- |
D6H |
-- |
AU@ |
-- |
WYU |
019 ## - |
-- |
958084149 |
-- |
958392409 |
-- |
1066462332 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9780323428668 |
Qualifying information |
electronic bk. |
|
International Standard Book Number |
0323428665 |
Qualifying information |
electronic bk. |
|
-- |
9780323428668 |
Qualifying information |
print |
|
International Standard Book Number |
9780323428897 |
|
International Standard Book Number |
0323428894 |
035 ## - |
-- |
(OCoLC)948296971 |
-- |
(OCoLC)958084149 |
-- |
(OCoLC)958392409 |
-- |
(OCoLC)1066462332 |
050 #4 - LIBRARY OF CONGRESS CALL NUMBER |
-- |
TA418.9.N35 |
072 #7 - |
-- |
TEC |
-- |
009000 |
-- |
bisacsh |
|
-- |
TEC |
-- |
035000 |
-- |
bisacsh |
082 04 - |
Classification number |
620.1/15 |
-- |
23 |
245 00 - TITLE STATEMENT |
Title |
Nanobiomaterials in drug delivery : |
Remainder of title |
applications of nanobiomaterials / |
Statement of responsibility, etc |
edited by Alexandru Mihai Grumezescu. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
1 online resource |
505 0# - |
Formatted contents note |
Front Cover; Nanobiomaterials in Drug Delivery; Copyright Page; Contents; List of contributors; Preface of the series; Preface; About the Series (Volumes I-XI); About Volume IX; 1 Nanobiomaterials in drug delivery; Abbreviations; 1.1 Introduction; 1.1.1 Parameters of Delivery of Nanoparticles into Biological Systems; 1.1.2 Intratumor Drug Release; 1.1.3 Biological Clearance; 1.1.4 Toxicity of Nanoparticles; 1.2 Preparation and Characterization of Nanomaterials; 1.2.1 Preparation; 1.2.2 Characterization; 1.2.2.1 Physicochemical characterization. |
|
Formatted contents note |
1.3 Nanotechnology-Assisted Formulating of Poorly Water-Soluble Compounds1.4 Biodegradable Polymers Used in Controlled Drug Delivery; 1.5 Multifunctional Nanomaterials for Cancer Therapy; 1.5.1 Targeting; 1.5.2 Imaging; 1.5.3 Chemotherapy; 1.6 Chemical Conjugation of Nanomaterials; 1.6.1 pH-Sensitive Linkages Used for Bioconjugation of Nanomaterials; 1.6.2 Other Chemical Linkages Used for Bioconjugation of Nanomaterials; 1.7 Conclusions; Acknowledgments; References; 2 Dendrimers in drug delivery; 2.1 Introduction; 2.2 Mechanisms of Interaction Between Dendrimers and Drug Molecules. |
|
Formatted contents note |
2.3 Dendrimers as Carriers of Various Types of Drugs2.3.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs); 2.3.2 Anticancer Drugs; 2.3.3 Other Drugs; 2.4 Routes of Administration of Drug-Dendrimers Complexes; 2.4.1 Dendrimers in Intravenous Drug Delivery; 2.4.2 Dendrimers in Oral Drug Delivery; 2.4.3 Dendrimers in Transdermal Drug Delivery; 2.4.4 Dendrimers in Ocular Drug Delivery; 2.4.5 Dendrimers in Pulmonary Drug Delivery; 2.5 Conclusions and Further Prognosis; Acknowledgments; References; 3 Lipid nanoparticles as non-viral vectors for siRNA delivery: concepts and applications. |
|
Formatted contents note |
3.1 Introduction3.2 siRNA: Definition, Mechanism, and Applications; 3.3 Hurdles for siRNA Delivery; 3.4 Strategies to Overcome the Hurdles of siRNA Delivery; 3.4.1 Chemical Modifications in siRNA; 3.4.2 Physical Methods for siRNA Delivery; 3.4.3 Viral Carriers for siRNA Delivery; 3.4.4 Non-viral Carriers for siRNA Delivery; 3.5 Liposomes: The Influence of Charge and Lipid Composition for siRNA Delivery; 3.5.1 Cationic Lipid-Based siRNA Delivery Systems; 3.5.2 Neutral Lipid-Based siRNA Delivery Systems; 3.5.3 Anionic Lipid-Based siRNA Delivery Systems; 3.5.4 Stealth Liposomes. |
|
Formatted contents note |
3.6 Targeted Delivery of siRNA-Loaded Liposomes3.7 Combined Therapy of siRNA-Loaded Liposomes and Conventional Small-Molecule Drugs; 3.8 siRNA-Loaded Liposomes Associated with Physical Methods; 3.9 siRNA-Loaded Liposomes: Clinical Studies; 3.10 Conclusions and Perspectives; References; 4 Nanobiomaterials: Novel nanoplatforms for protein and peptide delivery; 4.1 Introduction; 4.2 Proteins/Peptides as Therapeutics; 4.2.1 Group I-Protein Therapeutics with Enzymatic or Regulatory Activity; 4.2.2 Group II-Protein Therapeutics with Special Targeting Activity; 4.2.3 Group III-Proteinaceous Vaccines. |
650 #0 - |
Topical term or geographic name as entry element |
Nanostructured materials. |
|
Topical term or geographic name as entry element |
Nanomedicine. |
|
Topical term or geographic name as entry element |
Nanobiotechnology. |
|
Topical term or geographic name as entry element |
TECHNOLOGY & ENGINEERING / Engineering (General) |
|
Topical term or geographic name as entry element |
TECHNOLOGY & ENGINEERING / Reference |
|
Topical term or geographic name as entry element |
Nanobiotechnology. |
|
Topical term or geographic name as entry element |
Nanomedicine. |
|
Topical term or geographic name as entry element |
Nanostructured materials. |
700 1# - |
Personal name |
Grumezescu, Alexandru Mihai, |
Relator term |
editor. |
856 40 - |
Uniform Resource Identifier |
http://www.sciencedirect.com/science/book/9780323428668 |
264 #1 - |
-- |
Kidlington, Oxford, UK : |
-- |
William Andrew is an imprint of Elsevier, |
-- |
2016. |
336 ## - |
-- |
text |
-- |
txt |
-- |
rdacontent |
337 ## - |
-- |
computer |
-- |
c |
-- |
rdamedia |
338 ## - |
-- |
online resource |
-- |
cr |
-- |
rdacarrier |
504 ## - |
-- |
Includes bibliographical references and index. |
588 0# - |
-- |
Online resource; title from PDF title page (ScienceDirect, viewed May 9, 2016). |
|
-- |
bisacsh |
|
-- |
bisacsh |
|
-- |
fast |
-- |
(OCoLC)fst01894713 |
|
-- |
fast |
-- |
(OCoLC)fst01744350 |
|
-- |
fast |
-- |
(OCoLC)fst01032630 |
655 #4 - |
-- |
Electronic books. |
856 40 - |
-- |
ScienceDirect |